Cost-Effectiveness of the Aerobika® Oscillating Positive Expiratory Pressure Device in the Management of Chronic Obstructive Pulmonary Disease Exacerbations in Canada.

Nguyen Xuan ThanhPhilip JacobsJason SuggettAndrew McIvorAlan G Kaplan

Published in: Canadian respiratory journal (2019)

Given one of the major treatment goals in the GOLD guidelines is to minimize the negative impact of exacerbations and prevent re-exacerbations, the Aerobika® OPEP device should be viewed as a potential component of a treatment strategy to improve symptom control and reduce the risk of re-exacerbations in patients with COPD.

Keyphrases

chronic obstructive pulmonary disease
cystic fibrosis
lung function
intensive care unit
public health
clinical practice
climate change
acute respiratory distress syndrome
global health
mechanical ventilation